- €103.29bn
- €105.46bn
- €65.45bn
- 51
- 14
- 12
- 13
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 70,478 | 49,912 | 52,149 | 58,763 | 65,446 |
Cost of Revenue | |||||
Gross Profit | 10,505 | 5,662 | 9,631 | 10,571 | 10,044 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69,139 | 50,422 | 46,807 | 53,438 | 60,846 |
Operating Profit | 1,339 | -510 | 5,342 | 5,325 | 4,600 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,064 | -1,130 | 5,027 | 5,075 | 4,769 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,325 | -1,169 | 4,174 | 4,136 | 3,613 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,362 | -1,133 | 4,213 | 4,247 | 3,789 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,362 | -1,133 | 4,213 | 4,247 | 3,789 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.94 | 0.393 | 5.23 | 5.64 | 5.03 |
Dividends per Share | |||||
Special Dividends per Share |